{"id":8572,"date":"2026-01-20T19:06:39","date_gmt":"2026-01-20T22:06:39","guid":{"rendered":"https:\/\/portal.pi.gov.br\/sesapi\/?p=8572"},"modified":"2026-01-20T19:06:40","modified_gmt":"2026-01-20T22:06:40","slug":"sesapi-participa-de-webinario-nacional-sobre-introducao-do-nirsevimabe-no-sus","status":"publish","type":"post","link":"https:\/\/portal.pi.gov.br\/sesapi\/2026\/01\/20\/sesapi-participa-de-webinario-nacional-sobre-introducao-do-nirsevimabe-no-sus\/","title":{"rendered":"Sesapi participa de webin\u00e1rio nacional sobre introdu\u00e7\u00e3o do Nirsevimabe no SUS"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<p>A Secretaria de Estado da Sa\u00fade do Piau\u00ed (Sesapi) participou nesta ter\u00e7a-feira, (20), do webin\u00e1rio nacional \u201cSUS: Introdu\u00e7\u00e3o do Anticorpo Monoclonal, Nirsevimabe, contra o V\u00edrus Sincicial Respirat\u00f3rio (VSR)\u201d, promovido pelo Minist\u00e9rio da Sa\u00fade. O evento \u00e9 voltado para profissionais de sa\u00fade, gestores do CONASS, CONASEMS e parceiros institucionais.<\/p>\n\n\n\n<p>O webin\u00e1rio tem como objetivo apresentar orienta\u00e7\u00f5es gerais e esclarecer d\u00favidas sobre a incorpora\u00e7\u00e3o do Nirsevimabe, anticorpo monoclonal indicado para a preven\u00e7\u00e3o de infec\u00e7\u00f5es graves causadas pelo VSR, uma das principais causas de hospitaliza\u00e7\u00f5es em beb\u00eas e crian\u00e7as pequenas no Brasil.<\/p>\n\n\n\n<p>A coordenadora de Imuniza\u00e7\u00e3o da Sesapi, B\u00e1rbara Pinheiro, destaca a import\u00e2ncia da participa\u00e7\u00e3o do estado nesse momento estrat\u00e9gico para o fortalecimento da prote\u00e7\u00e3o da sa\u00fade infantil. \u201cEstamos acompanhando de perto a introdu\u00e7\u00e3o do Nirsevimabe no SUS porque se trata de um avan\u00e7o significativo na preven\u00e7\u00e3o de doen\u00e7as respirat\u00f3rias graves em crian\u00e7as. A Sesapi est\u00e1 comprometida em garantir que essa nova estrat\u00e9gia seja bem compreendida e implementada de forma segura e eficaz em todo o Piau\u00ed\u201d, ressalta.<\/p>\n\n\n\n<p>Durante o webin\u00e1rio, especialistas do Minist\u00e9rio da Sa\u00fade abordaram o cen\u00e1rio epidemiol\u00f3gico do VSR no Brasil, a estrat\u00e9gia nacional de prote\u00e7\u00e3o com o uso do anticorpo monoclonal, al\u00e9m de orienta\u00e7\u00f5es sobre seguran\u00e7a, manejo, log\u00edstica e registro das doses nos sistemas oficiais de informa\u00e7\u00e3o em sa\u00fade.<\/p>\n\n\n\n<p>A Sesapi refor\u00e7a a import\u00e2ncia da participa\u00e7\u00e3o dos profissionais de sa\u00fade do estado no evento, como forma de atualiza\u00e7\u00e3o t\u00e9cnica e alinhamento \u00e0s novas diretrizes do Sistema \u00danico de Sa\u00fade, contribuindo para a redu\u00e7\u00e3o de casos graves e interna\u00e7\u00f5es por infec\u00e7\u00f5es respirat\u00f3rias em crian\u00e7as.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Secretaria de Estado da Sa\u00fade do Piau\u00ed (Sesapi) participou nesta ter\u00e7a-feira, (20), do webin\u00e1rio nacional \u201cSUS: Introdu\u00e7\u00e3o do Anticorpo Monoclonal, Nirsevimabe, contra o V\u00edrus Sincicial Respirat\u00f3rio (VSR)\u201d, promovido pelo [&hellip;]<\/p>\n","protected":false},"author":1814,"featured_media":8573,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[30],"tags":[52,142,43,36,85],"featured_image_urls":{"full":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211.jpg",1600,1066,false],"thumbnail":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-150x150.jpg",150,150,true],"medium":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-300x200.jpg",300,200,true],"medium_large":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-768x512.jpg",768,512,true],"large":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-1024x682.jpg",887,591,true],"sgg-420":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-420x280.jpg",420,280,true],"sgg-540":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-540x360.jpg",540,360,true],"sgg-780":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-780x520.jpg",780,520,true],"1536x1536":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-1536x1023.jpg",1536,1023,true],"2048x2048":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211.jpg",1600,1066,false],"homepage-slider":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-1270x500.jpg",1270,500,true],"homepage-slider-small":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-947x500.jpg",947,500,true],"page-top":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-947x631.jpg",947,631,true],"page-small":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-624x416.jpg",624,416,true],"loop-main":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-365x240.jpg",365,240,true],"thumb-gallery-widget":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-84x56.jpg",84,56,true]},"post_excerpt_stackable":"<p>A Secretaria de Estado da Sa\u00fade do Piau\u00ed (Sesapi) participou nesta ter\u00e7a-feira, (20), do webin\u00e1rio nacional \u201cSUS: Introdu\u00e7\u00e3o do Anticorpo Monoclonal, Nirsevimabe, contra o V\u00edrus Sincicial Respirat\u00f3rio (VSR)\u201d, promovido pelo Minist\u00e9rio da Sa\u00fade. O evento \u00e9 voltado para profissionais de sa\u00fade, gestores do CONASS, CONASEMS e parceiros institucionais. O webin\u00e1rio tem como objetivo apresentar orienta\u00e7\u00f5es gerais e esclarecer d\u00favidas sobre a incorpora\u00e7\u00e3o do Nirsevimabe, anticorpo monoclonal indicado para a preven\u00e7\u00e3o de infec\u00e7\u00f5es graves causadas pelo VSR, uma das principais causas de hospitaliza\u00e7\u00f5es em beb\u00eas e crian\u00e7as pequenas no Brasil. A coordenadora de Imuniza\u00e7\u00e3o da Sesapi, B\u00e1rbara Pinheiro, destaca a import\u00e2ncia&hellip;<\/p>\n","category_list":"<a href=\"https:\/\/portal.pi.gov.br\/sesapi\/category\/noticias\/\" rel=\"category tag\">Not\u00edcias<\/a>","author_info":{"name":"elisangelapegado","url":"https:\/\/portal.pi.gov.br\/sesapi\/author\/elisangelapegado\/"},"comments_num":"0 coment\u00e1rio","featured_image_urls_v2":{"full":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211.jpg",1600,1066,false],"thumbnail":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-150x150.jpg",150,150,true],"medium":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-300x200.jpg",300,200,true],"medium_large":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-768x512.jpg",768,512,true],"large":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-1024x682.jpg",887,591,true],"sgg-420":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-420x280.jpg",420,280,true],"sgg-540":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-540x360.jpg",540,360,true],"sgg-780":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-780x520.jpg",780,520,true],"1536x1536":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-1536x1023.jpg",1536,1023,true],"2048x2048":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211.jpg",1600,1066,false],"homepage-slider":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-1270x500.jpg",1270,500,true],"homepage-slider-small":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-947x500.jpg",947,500,true],"page-top":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-947x631.jpg",947,631,true],"page-small":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-624x416.jpg",624,416,true],"loop-main":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-365x240.jpg",365,240,true],"thumb-gallery-widget":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211-84x56.jpg",84,56,true]},"post_excerpt_stackable_v2":"<p>A Secretaria de Estado da Sa\u00fade do Piau\u00ed (Sesapi) participou nesta ter\u00e7a-feira, (20), do webin\u00e1rio nacional \u201cSUS: Introdu\u00e7\u00e3o do Anticorpo Monoclonal, Nirsevimabe, contra o V\u00edrus Sincicial Respirat\u00f3rio (VSR)\u201d, promovido pelo Minist\u00e9rio da Sa\u00fade. O evento \u00e9 voltado para profissionais de sa\u00fade, gestores do CONASS, CONASEMS e parceiros institucionais. O webin\u00e1rio tem como objetivo apresentar orienta\u00e7\u00f5es gerais e esclarecer d\u00favidas sobre a incorpora\u00e7\u00e3o do Nirsevimabe, anticorpo monoclonal indicado para a preven\u00e7\u00e3o de infec\u00e7\u00f5es graves causadas pelo VSR, uma das principais causas de hospitaliza\u00e7\u00f5es em beb\u00eas e crian\u00e7as pequenas no Brasil. A coordenadora de Imuniza\u00e7\u00e3o da Sesapi, B\u00e1rbara Pinheiro, destaca a import\u00e2ncia&hellip;<\/p>\n","category_list_v2":"<a href=\"https:\/\/portal.pi.gov.br\/sesapi\/category\/noticias\/\" rel=\"category tag\">Not\u00edcias<\/a>","author_info_v2":{"name":"elisangelapegado","url":"https:\/\/portal.pi.gov.br\/sesapi\/author\/elisangelapegado\/"},"comments_num_v2":"0 coment\u00e1rio","jetpack_featured_media_url":"https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/01\/IMG-20231009-WA0211.jpg","_links":{"self":[{"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/posts\/8572"}],"collection":[{"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/users\/1814"}],"replies":[{"embeddable":true,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/comments?post=8572"}],"version-history":[{"count":1,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/posts\/8572\/revisions"}],"predecessor-version":[{"id":8574,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/posts\/8572\/revisions\/8574"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/media\/8573"}],"wp:attachment":[{"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/media?parent=8572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/categories?post=8572"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/tags?post=8572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}